Scott Chetham Co-Founded Faro AI Raises $37.3M in Series B Funding

Faro AI, Inc., a San Diego, CA-based developer of structured data and AI infrastructure for modern clinical development, has raised $37.3 million in a Series B financing round co-led by Merck Global Health Innovation Fund and S32.

The round also saw participation from all existing investors, including General Catalyst, Northpond Ventures, Polaris Partners, PTX Capital, and Zetta, and new investors, including Ankona Capital.

The company will use the funding to expand its agentic AI capabilities and help pharmaceutical companies deploy AI agents across clinical development.

Funding Snapshot

About Faro AI

Founded in 2019, by Scott Chetham, Faro AI develops structured data and AI infrastructure designed to help pharmaceutical companies improve clinical development. Its platform converts complex scientific, medical, regulatory and operational information into structured data that AI systems can understand and use.

Read More:Clean Tech Startup Teragen Energy Raises $6M in Pre-Seed Funding

Faro's platform is currently used by six of the world's 10 largest pharmaceutical companies.

Core offerings include:

• Clinical development data models
• Structured clinical data
• Agentic AI infrastructure
• AI-powered workflow automation

Core Technologies / Products / Services